Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 10:49AM ET
0.7588
Dollar change
+0.0269
Percentage change
3.68
%
IndexRUT P/E- EPS (ttm)-0.75 Insider Own53.35% Shs Outstand361.49M Perf Week10.74%
Market Cap274.30M Forward P/E- EPS next Y-0.46 Insider Trans0.00% Shs Float168.63M Perf Month-40.25%
Income-214.88M PEG- EPS next Q-0.13 Inst Own29.64% Short Float18.70% Perf Quarter-55.10%
Sales5.23M P/S52.45 EPS this Y14.05% Inst Trans7.06% Short Ratio9.35 Perf Half Y-60.68%
Book/sh0.49 P/B1.54 EPS next Y32.56% ROA-71.91% Short Interest31.53M Perf Year-39.30%
Cash/sh0.71 P/C1.06 EPS next 5Y- ROE-135.14% 52W Range0.62 - 3.73 Perf YTD-50.41%
Dividend Est.- P/FCF- EPS past 5Y6.80% ROI-75.91% 52W High-79.66% Beta1.06
Dividend TTM- Quick Ratio7.43 Sales past 5Y186.21% Gross Margin82.90% 52W Low22.31% ATR (14)0.09
Dividend Ex-Date- Current Ratio7.45 EPS Y/Y TTM1.42% Oper. Margin-4037.43% RSI (14)33.72 Volatility10.11% 9.95%
Employees285 Debt/Eq0.59 Sales Y/Y TTM884.75% Profit Margin-4109.41% Recom1.67 Target Price3.60
Option/ShortYes / Yes LT Debt/Eq0.59 EPS Q/Q13.09% Payout- Rel Volume1.57 Prev Close0.73
Sales Surprise-41.54% EPS Surprise-10.57% Sales Q/Q980.25% EarningsNov 12 AMC Avg Volume3.37M Price0.76
SMA20-7.33% SMA50-42.47% SMA200-56.36% Trades Volume1,286,077 Change3.68%
Date Action Analyst Rating Change Price Target Change
Jun-17-24Initiated H.C. Wainwright Buy $10
Apr-30-24Initiated Leerink Partners Outperform $5
Mar-07-23Initiated Jefferies Hold $3
Aug-12-22Initiated Piper Sandler Overweight $10
Jan-29-21Upgrade JP Morgan Underweight → Neutral $7
Jan-29-21Downgrade Wedbush Outperform → Neutral $2 → $8
Dec-08-20Upgrade Citigroup Neutral → Buy
Nov-18-20Upgrade Gabelli & Co Hold → Buy
Dec-11-19Downgrade Gabelli & Co Buy → Hold
Nov-08-19Downgrade Citigroup Buy → Neutral $3 → $4
Nov-27-24 07:30AM
Nov-26-24 08:00AM
Nov-25-24 04:15PM
Nov-22-24 07:32AM
05:05AM
04:05PM Loading…
Nov-20-24 04:05PM
Nov-14-24 08:00AM
Nov-13-24 02:20AM
Nov-12-24 05:25PM
04:25PM
04:05PM
Nov-11-24 07:15AM
Nov-07-24 05:02PM
Nov-06-24 08:00AM
02:58AM
04:05PM Loading…
Nov-05-24 04:05PM
08:00AM
Nov-04-24 08:00AM
Oct-31-24 06:54PM
Oct-27-24 05:35PM
Oct-23-24 09:00AM
Oct-22-24 08:00AM
Oct-17-24 07:15AM
05:55AM
Oct-16-24 04:35PM
04:34PM
Oct-09-24 03:53PM
Sep-27-24 08:00AM
Sep-16-24 08:00AM
Sep-10-24 08:00AM
04:00PM Loading…
Sep-03-24 04:00PM
08:00AM
Sep-01-24 10:26PM
Aug-29-24 08:41PM
Aug-22-24 11:26AM
10:33AM
Aug-21-24 08:00AM
Aug-14-24 12:33PM
Aug-13-24 08:30AM
07:00AM
Aug-07-24 08:00AM
Aug-01-24 05:15PM
04:12PM
04:00PM
Jul-25-24 08:00AM
Jul-17-24 11:15AM
Jul-16-24 08:00AM
Jul-15-24 08:00AM
Jul-08-24 09:15AM
Jun-21-24 08:00AM
Jun-19-24 08:00AM
Jun-18-24 08:00AM
Jun-14-24 08:00AM
May-30-24 04:45AM
May-29-24 07:30AM
May-14-24 08:03AM
07:00AM
May-09-24 07:30AM
May-06-24 10:05AM
May-03-24 07:46AM
04:07AM
May-02-24 08:59PM
06:05PM
06:03PM
05:00PM
04:05PM
Apr-29-24 10:42AM
09:00AM
07:00AM
Apr-18-24 08:00AM
Apr-16-24 12:00PM
Apr-03-24 08:00AM
Mar-25-24 09:20AM
Mar-13-24 12:45PM
Mar-12-24 08:00AM
Mar-11-24 08:25AM
07:34AM
07:15AM
07:05AM
07:00AM
Feb-29-24 10:00AM
Feb-22-24 12:58PM
Jan-31-24 05:06AM
Jan-23-24 05:21AM
Jan-08-24 07:00AM
Dec-26-23 05:06AM
Dec-21-23 04:15PM
Nov-30-23 07:30AM
Nov-22-23 07:30AM
Nov-15-23 01:03AM
Nov-12-23 02:10PM
Nov-10-23 04:01PM
10:53AM
Nov-08-23 09:45PM
07:19AM
07:00AM
Nov-03-23 09:00AM
Nov-02-23 09:00AM
Nov-01-23 09:00AM
Oct-31-23 04:01PM
Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its drug candidates include: LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain, and Sotagliflozin, a treatment for heart failure and type 1 diabetes. The company was founded by Brian P. Zambrowicz and Arthur T. Sands on July 7, 1995 and is headquartered in The Woodlands, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COATS LONNELFormer AffiliateAug 15 '24Proposed Sale1.60300,000480,000Aug 15 04:47 PM
Swain Judith LDirectorApr 28 '24Option Exercise0.008,032048,364Apr 29 04:21 PM
SOBECKI CHRISTOPHER JDirectorApr 28 '24Option Exercise0.008,0320167,055Apr 29 04:20 PM
LEFKOWITZ ROBERT J MDDirectorApr 28 '24Option Exercise0.008,032048,364Apr 29 04:18 PM
DEBBANE RAYMONDDirectorApr 28 '24Option Exercise0.008,03201,348,879Apr 29 04:17 PM
BARKER SAM LDirectorApr 28 '24Option Exercise0.008,032087,649Apr 29 04:17 PM
Amouyal PhilippeDirectorApr 28 '24Option Exercise0.008,0320248,364Apr 29 04:16 PM